Loading...
FRESENIUS KABI MALAYSIA SDN BHD — Gemcitabine Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #18 buyer for Gemcitabine · $480.2K import value · 29 shipments · MALAYSIA · DGFT Verified
FRESENIUS KABI MALAYSIA SDN BHD is the #18 importer of Gemcitabine from India with $480.2K in import value and 29 verified shipments. FRESENIUS KABI MALAYSIA SDN BHD holds a 1.0% market share in Gemcitabine imports based in MALAYSIA. The company sources from 1 verified supplier across 26 formulations shipped to 1 country. Overall, FRESENIUS KABI MALAYSIA SDN BHD imports 8 pharmaceutical products worth $3.5M across 2 therapeutic categories.
Verified from 29 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $480.2K | 29 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD sources Gemcitabine from 1 verified Indian supplier based on 29 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 17 | FRESENIUS KABI (THAILAND) LTD | THAILAND | $580.0K | 13 | $44.6K |
| 7 | MYLAN INSTITUTIONAL INC | UNITED STATES | $550.0K | 11 | $50.0K |
| 18 | FRESENIUS KABI MALAYSIA SDN BHD ★ | MALAYSIA | $482.4K | 27 | $17.9K |
| 10 | EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $450.0K | 9 | $50.0K |
| 15 | OOOJODAS EXPOIM | RUSSIA | $450.0K | 9 | $50.0K |
FRESENIUS KABI MALAYSIA SDN BHD ranks #18 among 676 Gemcitabine importers from India. Average shipment value of $17.9K compared to the market average of $29.2K. The closest competitors by value are FRESENIUS KABI (THAILAND) LTD and MYLAN INSTITUTIONAL INC.
Destination countries from 29 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $480.2K | 29 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD imports Gemcitabine to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $480.2K.
| Formulation | Value | Shipments |
|---|---|---|
| GEMITA ( GEMCITABINE ) INJ. 1GM/26.3ML V | $88.5K | 2 |
| GEMITA ( GEMCITABINE ) INJ. 1GM/26.3ML VIAL, BATCH NO. 87240066BG, MFG. DT. 02/2024, EXP. DT. 01/2026 | $50.0K | 1 |
| GEMITA (GEMCITABINE) INJ. 1GM/26.3ML VIA | $40.9K | 1 |
| GEMITA ( GEMCITABINE ) INJ. 1GM/26.3ML VIAL BATCH NO. 87230545BA MFG. DT. 12/2023 EXP. DT. 11/2025NOS | $40.8K | 1 |
| GEMITA (GEMCITABINE) USP INJ. 1GM/26.3MLVIAL (BATCH NO. 87250079BB, MFG. DT. 03/2025, EXP. DT. 02/2027) | $25.1K | 1 |
| GEMITA (GEMCITABINE) INJ. 1GM/26.3ML VIAL(BATCH NO. 87250051AE, MFG. DT. 02/2025, EXP. DT. 01/2027) | $24.9K | 1 |
| GEMITA GEMCITABINE INJ. 1GM/26.3ML V | $22.0K | 1 |
| GEMITA (GEMCITABINE) INJ. 1GM/VIAL BATCH | $20.6K |
India exported $19.7M worth of Gemcitabine through 2,938 shipments from 248 suppliers to 125 countries, serving 676 buyers globally. FRESENIUS KABI MALAYSIA SDN BHD imports $480.2K of this total, accounting for 1.0% of India's Gemcitabine exports with 29 shipments from MALAYSIA. This is verified from 29 customs shipment records covering 26 distinct formulations.
FRESENIUS KABI MALAYSIA SDN BHD's average Gemcitabine order value is $16.6K per consignment, based on 29 shipments totaling $480.2K. FRESENIUS KABI MALAYSIA SDN BHD is based in MALAYSIA and ranks #18 among all Gemcitabine importers from India by value. The company sources from 1 verified supplier in India.
FRESENIUS KABI MALAYSIA SDN BHD sources Gemcitabine from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($480.2K, 100.0%). This is based on 29 customs records.
FRESENIUS KABI MALAYSIA SDN BHD ranks #18 among 676 Gemcitabine importers from India with a 1.0% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($5.1M), EUGIA PHARMA (MALTA) LTD, ($3.4M), PHARMACIE CENTRALE DES HOPITAUX ($2.1M). FRESENIUS KABI MALAYSIA SDN BHD processed 29 shipments from MALAYSIA.
FRESENIUS KABI MALAYSIA SDN BHD also imports these oncology products. Each links to the detailed product page.
FRESENIUS KABI MALAYSIA SDN BHD imports 8 products worth $3.5M. Beyond Gemcitabine, top products include Carboplatin, Oxaliplatin, Docetaxel, Epirubicin, Cytarabine. View the complete FRESENIUS KABI MALAYSIA SDN BHD profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI MALAYSIA SDN BHD's Gemcitabine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI MALAYSIA SDN BHD
Full Company Profile →
8 products · $3.5M total trade · 2 categories
| 1 |
| GEMITA GEMCITABINE USP INJ 1GM VIAL BATCH NO 87250151AB MFG DT 04 2025 EXP DT 03 2027 | $19.2K | 2 |
| GEMITA ( GEMCITABINE ) INJ. 200MG/5.26ML | $18.9K | 2 |
FRESENIUS KABI MALAYSIA SDN BHD imports 26 distinct Gemcitabine formulations from India. The top formulation is GEMITA ( GEMCITABINE ) INJ. 1GM/26.3ML V with 2 shipments worth $88.5K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 125+ countries, 676+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI MALAYSIA SDN BHD.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gemcitabine. For current order-level data, contact TransData Nexus.